{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:15:27Z","timestamp":1742012127623,"version":"3.38.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T00:00:00Z","timestamp":1322006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11096-011-9581-3","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T08:54:24Z","timestamp":1321952064000},"page":"905-908","source":"Crossref","is-referenced-by-count":4,"title":["Ventricular bigeminy associated with voriconazole, methadone and esomeprazole"],"prefix":"10.1007","volume":"33","author":[{"given":"Julie","family":"Scholler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"Nivoix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Kemmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Lev\u00eaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,23]]},"reference":[{"key":"9581_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1517\/14740338.6.3.289","volume":"6","author":"GB Ehret","year":"2007","unstructured":"Ehret GB, Desmeules JA, Broers B. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned from pharmacology. Expert Opin Drug Saf. 2007;6:289\u2013303.","journal-title":"Expert Opin Drug Saf."},{"key":"9581_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","volume":"108","author":"RA Totah","year":"2008","unstructured":"Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology. 2008;108:363\u201374.","journal-title":"Anesthesiology."},{"key":"9581_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijantimicag.2006.01.003","volume":"27","author":"D Lev\u00eaque","year":"2006","unstructured":"Lev\u00eaque D, Nivoix Y, Jehl F, Herbrecht R. Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents. 2006;27:274\u201384.","journal-title":"Int J Antimicrob Agents."},{"key":"9581_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/AAC.01123-08","volume":"53","author":"S Jeong","year":"2009","unstructured":"Jeong S, Nguyen PD, Desta Z. Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes; major effects of CYPs 2B6, 2C9, 2C19, and 3A4. Antimicrob Agents Chemother. 2009;53:541\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"9581_CR5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0090-9556(24)15171-9","volume":"28","author":"A \u00c4bel\u00f6","year":"2000","unstructured":"\u00c4bel\u00f6 A, Andersson TB, Antonsson M, Naudot AK, Skanberg I, Weidolf L. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Drug Metab Dispos. 2000;28:966\u201372.","journal-title":"Drug Metab Dispos"},{"key":"9581_CR6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","volume":"32","author":"XQ Li","year":"2004","unstructured":"Li XQ, Andersson TB, Ahlstr\u00f6m M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lanzoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004;32:821\u20137.","journal-title":"Drug Metab Dispos"},{"key":"9581_CR7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/AAC.00559-06","volume":"51","author":"P Liu","year":"2007","unstructured":"Liu P, Foster G, LaBadie R, Somoza E, Sharma A. Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy. Antimicrob Agents Chemother. 2007;51:110\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"9581_CR8","doi-asserted-by":"crossref","first-page":"56 Suppl 1","DOI":"10.1046\/j.1365-2125.2003.02000.x","volume":"56","author":"N Wood","year":"2003","unstructured":"Wood N, Tan K, Purkins L, Layton G, Hamlin J, Kleinermans D, Nichols D. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. Br J Clin Pharmacol. 2003;56 Suppl 1:56\u201361.","journal-title":"Br J Clin Pharmacol"},{"key":"9581_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","volume":"46","author":"A Pascual","year":"2008","unstructured":"Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46:201\u201311.","journal-title":"Clin Infect Dis"},{"key":"9581_CR10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijantimicag.2006.11.011","volume":"29","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Rafailidis PI, Rosmarakis ES. Arrhythmias associated with fluoroquinolone therapy. Int J Antimicrob Agents. 2007;29:374\u20139.","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-011-9581-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-011-9581-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-011-9581-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:23:07Z","timestamp":1741944187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-011-9581-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,23]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9581"],"URL":"https:\/\/doi.org\/10.1007\/s11096-011-9581-3","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2011,11,23]]}}}